Last $73.85 USD
Change Today +0.15 / 0.20%
Volume 5.8M
ITMN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John C. Hodgman B.S., M.B.A.

Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Finance, InterMune, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 4 different industries.

See Board Relationships
59$1,060,836
As of Fiscal Year 2013

Background*

Mr. John C. Hodgman, B.S., M.B.A. has been the Chief Financial Officer at InterMune Inc. since August 14, 2006 and Executive Vice President of Finance since March 2013. Mr. Hodgman has been Principal Accounting Officer at InterMune Inc. since June 8, 2012. Mr. Hodgman served as Senior Vice President of Finance & Administration at InterMune Inc. since August 14, 2006 until March 2013. He previously held senior leadership positions at a number of biotechnology and technology ...

Read Full Background

Corporate Headquarters*

3280 Bayshore Boulevard
Brisbane, California 94005

United States

Phone: 415-466-2200
Fax: 415-466-2300

Board Members Memberships*

1998-N/A
Former Chairman of the Board and Member of Employee Stock Option Committee
2002-N/A
Former Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2004-Present
Interim Chairman, Chairman of Audit Committee and Member of Compensation Committee
2005-2005
Former Chief Executive Officer, President and Director
2005-N/A
Former Independent Director
2006-2006
Former Director

Education*

MBA
The University of Utah
BS
Brigham Young University

Other Affiliations*

Annual Compensation*

Salary$412,000
Total Annual Compensation$412,000

Stock Options*

Restricted Stock Awards$89,910
All Other Compensation$58,198
Exercisable Options143,700
Exercisable Options Value$585,769
Unexercisable Options73,073
Unexercisable Options Value$314,581
Total Value of Options$900,350
Total Number of Options216,773

Total Compensation*

Total Annual Cash Compensation$656,916
Total Short Term Compensation$412,000
Other Long Term Compensation$148,108
Total Calculated Compensation$1,060,836
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ITMN:US $73.85 USD +0.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$1.8M
David T. Hung M.D.Founder, Chief Executive Officer, President and Executive Director
Medivation, Inc.
$750.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTERMUNE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.